{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:03:54Z","timestamp":1771707834100,"version":"3.50.1"},"reference-count":27,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>To determine if the potent antiglioma chemotherapeutic agent gemcitabine could be delivered to the brainstem safely at therapeutic doses while monitoring its distribution using a surrogate magnetic resonance (MR) imaging tracer, the authors used convection-enhanced delivery to perfuse the primate brainstem with gemcitabine and Gd\u2013diethylenetriamine pentaacetic acid (DTPA).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Six primates underwent convective brainstem perfusion with gemcitabine (0.4 mg\/ml; two animals), Gd-DTPA (5 mM; two animals), or a coinfusion of gemcitabine (0.4 mg\/ml) and Gd-DTPA (5 mM; two animals), and were killed 28 days afterward. These primates were observed over time clinically (six animals), and with MR imaging (five animals), quantitative autoradiography (one animal), and histological analysis (all animals). In an additional primate, <jats:sup>3<\/jats:sup>H-gemcitabine and Gd-DTPA were coinfused and the animal was killed immediately afterward.<\/jats:p>\n<jats:p>In the primates there was no histological evidence of infusate-related tissue toxicity. Magnetic resonance images obtained during infusate delivery demonstrated that the anatomical region infused with Gd-DTPA was clearly distinguishable from surrounding noninfused tissue. Quantitative autoradiography confirmed that Gd-DTPA tracked the distribution of <jats:sup>3<\/jats:sup>H-gemcitabine and closely approximated its volume of distribution (mean volume of distribution difference 13.5%).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Gemcitabine can be delivered safely and effectively to the primate brainstem at therapeutic concentrations and at volumes that are higher than those considered clinically relevant. Moreover, MR imaging can be used to track the distribution of gemcitabine by adding Gd-DTPA to the infusate. This delivery paradigm should allow for direct therapeutic application of gemcitabine to brainstem gliomas while monitoring its distribution to ensure effective tumor coverage and to maximize safety.<\/jats:p><\/jats:sec>","DOI":"10.3171\/jns.2007.106.2.351","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T12:44:23Z","timestamp":1201178663000},"page":"351-356","source":"Crossref","is-referenced-by-count":56,"title":["Image-guided convection-enhanced delivery of gemcitabine to the brainstem"],"prefix":"10.3171","volume":"106","author":[{"given":"Gregory J. A.","family":"Murad","sequence":"first","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke"},{"name":"2Department of Neurosurgery, University of Florida, Gainesville, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Walbridge","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Morrison","sequence":"additional","affiliation":[{"name":"3Division of Bioengineering and Physical Science, Office of Research Services"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Szerlip","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke"},{"name":"4Department of Neurosurgery, University of Maryland, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Butman","sequence":"additional","affiliation":[{"name":"5Section of Neuroradiology, Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward H.","family":"Oldfield","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell R.","family":"Lonser","sequence":"additional","affiliation":[{"name":"1Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-1060351","series-title":"Neurosurg Clin N Am","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1042-3680(18)30576-X","article-title":"Tumors of the pons","volume":"4","year":"1993"},{"key":"b2-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3171\/jns.1986.65.6.0751","article-title":"Prognostic factors in pediatric brain-stem gliomas","volume":"65","year":"1986"},{"key":"b3-1060351","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000121024","article-title":"Contemporary chemotherapy issues for children with brainstem gliomas","volume":"24","year":"1996"},{"key":"b4-1060351","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","year":"1994"},{"key":"b5-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3171\/jns.2003.99.5.0893","article-title":"Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats","volume":"99","year":"2003"},{"key":"b6-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/jns.1993.78.3.0408","article-title":"Brain-stem glioma growth patterns","volume":"78","year":"1993"},{"key":"b7-1060351","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000056021","article-title":"Brainstem Gliomas. A 10-year institutional review","volume":"34","year":"2001"},{"key":"b8-1060351","series-title":"Pediatr Neurosurg","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000121010","article-title":"Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome","volume":"24","year":"1996"},{"key":"b9-1060351","series-title":"J Neurooncol","first-page":"207","article-title":"Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyper-fractionated radiotherapy and chemotherapy","volume":"28","year":"1996"},{"key":"b10-1060351","series-title":"Pediatr Neurosurg","first-page":"185","article-title":"Brainstem gliomas in children. A Children\u2019s Cancer Group review of 119 cases","volume":"24","year":"1996"},{"key":"b11-1060351","series-title":"Cancer Res","first-page":"1337","article-title":"Effect of tetrahydrouridine on the clinical pharmacology of 1-\u03b2-D-arabinofuranosylcytosine when both drugs are coinfused over three hours","volume":"48","year":"1988"},{"key":"b12-1060351","series-title":"Science","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1126\/science.2218494","article-title":"New methods of drug delivery","volume":"249","year":"1990"},{"key":"b13-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3171\/jns.1997.87.4.0586","article-title":"Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging","volume":"87","year":"1997"},{"key":"b14-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3171\/jns.1995.82.6.1021","article-title":"Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion","volume":"82","year":"1995"},{"key":"b15-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3171\/jns.1998.89.4.0616","article-title":"Direct convective delivery of macromolecules to the spinal cord","volume":"89","year":"1998"},{"key":"b16-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3171\/jns.2002.97.4.0905","article-title":"Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion","volume":"97","year":"2002"},{"key":"b17-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3171\/jns.1998.89.4.0610","article-title":"Direct convective delivery of macromolecules to peripheral nerves","volume":"89","year":"1998"},{"key":"b18-1060351","series-title":"Principles of Clinical Pharmacology","first-page":"93","article-title":"Distribution models of drug kinetics","year":"2001"},{"key":"b19-1060351","series-title":"Am J Physiol","first-page":"R292","article-title":"High-flow microinfusion: tissue penetration and pharmacodynamics","volume":"266","year":"1994"},{"key":"b20-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3171\/jns.2003.98.3.0584","article-title":"Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging","volume":"98","year":"2003"},{"key":"b21-1060351","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/1097-0142(19940915)74:6<1827::AID-CNCR2820740628>3.0.CO;2-Q","article-title":"Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I\/II Trial","volume":"74","year":"1994"},{"key":"b22-1060351","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/1097-0142(19930815)72:4<1414::AID-CNCR2820720442>3.0.CO;2-C","article-title":"Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I\/II Trial","volume":"72","year":"1993"},{"key":"b23-1060351","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2150::AID-CNCR28>3.0.CO;2-T","article-title":"Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a Childrens Cancer Group Phase I\/II Study","volume":"77","year":"1996"},{"key":"b24-1060351","series-title":"J Cereb Blood Flow Metab","first-page":"713","article-title":"Drug delivery to the brain","volume":"17","year":"1997"},{"key":"b25-1060351","series-title":"The Chemotherapy Source Book","year":"2001"},{"key":"b26-1060351","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3171\/jns.1993.79.6.0845","article-title":"Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases","volume":"79","year":"1993"},{"key":"b27-1060351","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0014-2999(98)00883-8","article-title":"Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone","volume":"365","year":"1999"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/106\/2\/article-p351.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/106\/2\/article-p351.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/106\/2\/article-p351.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T10:09:42Z","timestamp":1709978982000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/106\/2\/article-p351.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":27,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/jns.2007.106.2.351","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}